Mumbai, September 18, 2025: QMS Medical Allied Services Ltd (NSE Code: QMSMEDI), a leading holistic healthcare management solutions company, opened its Rights Issue on September 12, 2025, to raise INR12.5 crore. The Issue comprises 14,87,500 equity shares of face value INR10 each, offered at an Issue Price of ₹81 per share (including a premium of INR71 per share).
Rights Issue details:
- Right Issue Ratio: 1:12 (1 equity share will be issued for every 12 equity shares held by shareholders
- Right Issue Price: INR81 per share (including a premium of INR71 per share)
- Issue Size: INR12.05 crore
- Record Date: 4th September 2025 & Renunciation of RE: 17th September 2025
- Issue open / close Date: 12th September 2025 till 22nd September 2025
The proceeds from the Rights Issue will be strategically utilised to strengthen QMS Medical Allied Services’ growth trajectory. A significant portion, amounting to INR10 crore, will be invested towards acquiring an additional 25% stake in its subsidiary, Saarathi Healthcare Private Limited, thereby increasing QMS Medical Allied Services’ holding to 76%. The balance funds will be deployed to meet working capital requirements and for general corporate purposes, ensuring enhanced operational flexibility and sustained business expansion.
Mahesh Makhija, Founder, Chairman and Managing Director, QMS Medical Allied Services Ltd., said, “The Rights Issue will support our planned acquisition of an additional 25% stake in Saarathi Healthcare Private Limited, further consolidating our position in the value-added segment of the healthcare industry. This strategic investment reinforces our commitment to expanding QMS Medical Allied Services’ footprint in high-growth verticals, enhancing operational synergies, and unlocking long-term value for all stakeholders.
“India’s healthcare sector continues to experience unprecedented growth, driven by rising demand for advanced medical solutions. At QMS Medical Allied Services, we remain steadfast in our mission to deliver accessible, high-quality, and dependable healthcare products and services across the country. This Rights Issue is not just a step towards accelerating our strategic initiatives, but also a valuable opportunity for our shareholders to strengthen their association with QMS Medical Allied Services and participate in our journey of sustained growth and innovation,” Makhija added.
About QMS Medical Allied Services Ltd – QMS Medical Allied Services Ltd (QMS MAS) is a leading healthcare company specialising in innovative patient screening services and the supply of advanced diagnostic medical devices. Through its pioneering Patient Service Programs (PSP), QMS MAS provides patients nationwide with access to critical diagnostic tests for conditions such as Osteoporosis, Diabetes Mellitus, Chronic Obstructive Pulmonary Disease, and Hypertension. Committed to promoting early intervention and preventive healthcare, QMS MAS plays a vital role in improving patient outcomes and enhancing the overall healthcare experience. With a dedication to excellence and a forward-thinking approach, QMS MAS continues to expand its impact in the healthcare industry, delivering value-added services that benefit patients and healthcare providers alike.